Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories nIH ClinicalTrials.gov — Cumulative Abbott-Sponsored Clinical Studies
NIH ClinicalTrials.gov Registry API v2 (2,098 Abbott-Sponsored Studies)
Latest, FY2025
2,065
Period ended Dec 31, 2025
Change on a year earlier
+2.2%
2,020 in FY2024
History
12 years
Since FY2014
Sources
1
NIH ClinicalTrials.gov Registry — Abbott Laboratories
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up nih clinicaltrials.gov — cumulative abbott-sponsored clinical studies
- ClinicalTrials.gov — New Abbott Clinical Studies Started45 · FY2025
- ClinicalTrials.gov — Interventional Studies Started (Abbott)29 · FY2025
- ClinicalTrials.gov — Observational Registry Studies Started (Abbott)16 · FY2025
- ClinicalTrials.gov — Target / Actual Patient Enrollment in Studies Started42,106 · FY2025
Cite this data
StockData. (2026). Abbott Laboratories NIH ClinicalTrials.gov — Cumulative Abbott-Sponsored Clinical Studies, annual FY2014–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ext-ct-cum
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.